BlackRock Fund Advisors’s Lipocine LPCN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $1.98M | Buy |
31,653
+4,265
| +16% | +$267K | ﹤0.01% | 3166 |
|
2016
Q3 | $2.08M | Buy |
27,388
+1,907
| +7% | +$145K | ﹤0.01% | 3151 |
|
2016
Q2 | $1.32M | Buy |
25,481
+23,389
| +1,118% | +$1.21M | ﹤0.01% | 3240 |
|
2016
Q1 | $361K | Sell |
2,092
-160
| -7% | -$27.6K | ﹤0.01% | 3294 |
|
2015
Q4 | $495K | Buy |
2,252
+99
| +5% | +$21.8K | ﹤0.01% | 3288 |
|
2015
Q3 | $433K | Sell |
2,153
-261
| -11% | -$52.5K | ﹤0.01% | 3256 |
|
2015
Q2 | $352K | Buy |
2,414
+722
| +43% | +$105K | ﹤0.01% | 3307 |
|
2015
Q1 | $198K | Buy |
1,692
+786
| +87% | +$92K | ﹤0.01% | 3486 |
|
2014
Q4 | $81K | Buy |
+906
| New | +$81K | ﹤0.01% | 3641 |
|